Autolus Therapeutics Plc Adr Azioni (AUTL) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 74.27%45.69 | 26.22 | 24.29 | 21.19 | 20.92 |
| Cost Of Revenue | 16.69%20.47 | 24.57 | 25.33 | 28.64 | 24.45 |
3.02%41.16 | 39.95 | 35.80 | - | - | |
| Selling, General, and Administrative | 3.02%41.16 | 39.95 | 35.80 | - | - |
| Research and Development | 31.53%27.90 | 21.21 | 35.63 | - | - |
| Interest Income/Expense | 124.04%-2.67 | 11.12 | 22.84 | 10.52 | -6.83 |
| Operating Income/Loss | 26.34%-43.84 | -59.51 | -72.47 | -71.62 | -61.22 |
| Nonoperating Income/Loss | 146.27%5.19 | -11.22 | -19.05 | -6.97 | 13.70 |
| Income/Loss From Continuing Operations Before Tax | 45.37%-38.65 | -70.74 | -91.52 | -78.59 | -47.52 |
| Income Tax Expense/Benefit | 46.12%0.47 | 0.86 | -1.18 | 0.53 | 0.40 |
45.37%-39.11 | -71.60 | -90.33 | -79.12 | -47.92 | |
| Attributable To Parent | 45.37%-39.11 | -71.60 | -90.33 | -79.12 | -47.92 |
| Available To Common Stockholders, Basic | 45.37%-39.11 | -71.60 | -90.33 | -79.12 | -47.92 |
| Basic Average Shares | 0.01%266.16 | 266.14 | - | 266.14 | 266.14 |
| Diluted Average Shares | 0.01%266.16 | 266.14 | - | 266.14 | 266.14 |
| Basic Earnings Per Share | 44.44%-0.15 | -0.27 | - | -0.30 | -0.18 |
| Diluted Earnings Per Share | 44.44%-0.15 | -0.27 | - | -0.30 | -0.18 |